Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04273061
Title Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (CAPTIV-8)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency

lung cancer

breast cancer

urinary system cancer


Advanced Solid Tumor

female reproductive organ cancer

hepatobiliary system cancer

male reproductive organ cancer

gastrointestinal system cancer

pancreatic cancer



Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.